Concepedia

Francesco Galimi

FG

Statistics

Publications

54

Citations

7.6K

H-Index

40

Active since

1993

Affiliations

University of Turin(Current)

Candiolo Cancer Institute

University of Sassari

Salk Institute for Biological Studies

Amgen (United States)

Francesco Galimi is an author at University of Turin specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1993–2024

54

Publications

54

A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Andrea Bertotti, Giorgia Migliardi, Francesco Galimi et al. · Cancer Discovery · 2011 · 953 citations · Full text

, , +17

Amplification of the <i>MET</i> Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer

Alberto Bardelli, Simona Corso, Andrea Bertotti et al. · Cancer Discovery · 2013 · 665 citations · Full text

, , +16

Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer

Claudio Isella, Francesco Brundu, Sara E. Bellomo et al. · Nature Communications · 2017 · 324 citations · Full text

, , +17

CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-γ

Stephan Herzig, Susan Hedrick, Ianessa Morantte et al. · Nature · 2003 · 320 citations

, , +14

Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3

Chong Sun, Sebastijan Hobor, Andrea Bertotti et al. · Cell Reports · 2014 · 316 citations · Full text

, , +17

1–5 of 54